Comparison of ESD outcome using different dose of PPI

Not Applicable

Active, not recruiting

• Conditions: Neoplasms

• Registration Number: KCT0004239
• Lead Sponsor: Kyung Hee University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 438

Inclusion Criteria

1)Over 19 years old patients who planned to undergo endoscopic submucosal dissection for gastric adenoma or early gastric caner.
2) Person who are agreed upon study enrollement.

Exclusion Criteria

1)Coagulopathy defined by Prothrombine time > 1.5 INR, activated partial thromboplastin time > 1.5 times above reference value
2)Previous history of stomach surgery
3)Allergic to PPI (Hypersensitivity or history of hypersensitivity to PPI itself, constituent of PPI or Benzimidazole)
4)Pregnant or lactating woman
5)If it is impossible to assess one's pain
6)Patients using atazanavir or nelfinavir
7)Patients using Rilpivirine-containing medication

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Delayed bleeding

Secondary Outcome Measures

Name	Time	Method
Severity of post procedural pain